Literature DB >> 2542533

Cyclic GMP: a potential mediator of neurally- and drug-induced relaxation of opossum lower esophageal sphincter.

M Barnette1, T J Torphy, M Grous, C Fine, H S Ormsbee.   

Abstract

Electrical field stimulation (EFS) of isolated strips of opossum lower esophageal sphincter (LES) produced a relaxation that was accompanied by an elevation of intracellular cyclic GMP content. In order to compare the time dependence of the EFS-induced relaxation with that of the elevation of cyclic GMP, the ability of EFS to produce relaxation and increase cyclic GMP was measured. The results of these experiments showed that cyclic GMP content increased before the onset of relaxation. Cumulative addition of atriopeptin II, an activator of particulate guanylate cyclase, produced a concentration-dependent relaxation of this tissue and increased cyclic GMP content. In other experiments, zaprinast, an inhibitor of a cyclic GMP selective-phosphodiesterase, produced a concentration-related relaxation of opossum LES and increased cyclic GMP content. However, pretreatment with zaprinast (3 microM) did not potentiate the EFS-induced relaxation or the increase in cyclic GMP content. At this concentration, however, zaprinast increased the basal content of cyclic GMP. Finally, 8-Br-cyclic GMP, a membrane-permeable analog of cyclic GMP, produced a concentration-dependent relaxation of isolated strips of opossum LES. In conclusion, these data extend the initial findings that an elevation in cyclic GMP content is associated with relaxation and suggest that cyclic GMP is a potential intracellular messenger of neurally- and drug-induced relaxation of opossum LES.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542533

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  12 in total

1.  A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle.

Authors:  N Kim; K M Azadzoi; I Goldstein; I Saenz de Tejada
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

2.  The effect of isoenzyme-selective PDE inhibitors on methacholine-induced contraction of guinea-pig and rat ileum.

Authors:  A Tomkinson; D Raeburn
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

3.  Nitric oxide-mediated relaxation without concomitant changes in cyclic GMP content of rat proximal colon.

Authors:  T Takeuchi; M Kishi; T Ishii; H Nishio; F Hata
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

Review 4.  Control of esophageal motor function.

Authors:  J L Conklin
Journal:  Dysphagia       Date:  1993       Impact factor: 3.438

5.  Nitric oxide activation of a potassium channel (BK(Ca)) in feline lower esophageal sphincter.

Authors:  Marie-Claude L'Heureux; Ahmad Muinuddin; Herbert Y Gaisano; Nicholas E Diamant
Journal:  World J Gastroenterol       Date:  2010-12-14       Impact factor: 5.742

6.  Pharmacologic specificity of nicotinic receptor-mediated relaxation of muscarinic receptor precontracted human gastric clasp and sling muscle fibers within the gastroesophageal junction.

Authors:  Alan S Braverman; Anil K Vegesna; Larry S Miller; Mary F Barbe; Mansoor Tiwana; Kashif Hussain; Michael R Ruggieri
Journal:  J Pharmacol Exp Ther       Date:  2011-04-04       Impact factor: 4.030

Review 7.  Regulation of basal tone, relaxation and contraction of the lower oesophageal sphincter. Relevance to drug discovery for oesophageal disorders.

Authors:  R Farré; D Sifrim
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

8.  Involvement of cyclic GMP in non-adrenergic, non-cholinergic inhibitory neurotransmission in dog proximal colon.

Authors:  S M Ward; H H Dalziel; M E Bradley; I L Buxton; K Keef; D P Westfall; K M Sanders
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

9.  Nitric oxide, an enteric nonadrenergic-noncholinergic relaxant transmitter: evidence using phosphodiesterase V and nitric oxide synthase inhibition.

Authors:  S J Williams; M E Parsons
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

10.  Evidence for the involvement of cGMP in neural bronchodilator responses in humal trachea.

Authors:  J K Ward; P J Barnes; S Tadjkarimi; M H Yacoub; M G Belvisi
Journal:  J Physiol       Date:  1995-03-01       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.